Altre lingue Arbutus Biopharma Corporation

Azioni

ABUS

CA03879J1003

Biotecnologia

Tempo reale stimato Cboe BZX Altri mercati azionari 21:39:41 14/04/2026			Variaz. 5gg	Var. 1 gen.
4,355 ^USD	-0,34%		-2,58%	-9,67%

23/03	Arbutus Biopharma Corporation riporta i risultati finanziari per l'esercizio chiuso al 31 dicembre 2025	CI
23/03	Arbutus Biopharma Corporation annuncia il raggiungimento della cura funzionale nei trial clinici di Fase 2a per Imdusiran	CI

Altre lingue

23/03	Arbutus Biopharma Corporation Reports Earnings Results for the Full Year Ended December 31, 2025
23/03	Arbutus Biopharma Corporation Announces Functional Cure Achievements in Phase 2A Clinical Trials of Imdusiran
23/03	Arbutus Biopharma 2025 Net Loss Narrows as Revenue Rises
23/03	Earnings Flash (ABUS) Arbutus Biopharma Posts 2025 Total Revenue $14.1M, vs. FactSet Est of $13.6M
23/03	Earnings Flash (ABUS) Arbutus Biopharma Posts 2025 Loss $0.17 a Share, vs. FactSet Est of $0.19 Loss
23/03	Arbutus: Q4 Earnings Snapshot
23/03	Arbutus Reports Fourth Quarter and Year End 2025 Financial Results and Provides Corporate Update
04/03	Health Care Up, But not by Much, on Cyclical Bias - Health Care Roundup
04/03	Equities Rise on Upbeat Data as Markets Look Past Middle East Conflict
04/03	US Equity Markets End Higher After Strong Services, Jobs Data
04/03	Moderna Shares Rise After Company Enters Settlement Agreement with Arbutus Biopharma, Genevant Sciences
04/03	Wall Street mixed as oil retreat eases inflation fears
04/03	Top Midday Stories: Bessent Says US to Fortify Gulf Oil Trade, 15% Tariff Rolling Out This Week; CrowdStrike Fiscal Q4 Adjusted Earnings, Revenue Increase
04/03	Wall Street sur une note mitigée, le reflux du pétrole apaise les craintes inflationnistes
04/03	Moderna rises on $2.25 billion settlement, clearing COVID vaccine patent dispute overhang
04/03	Moderna to pay $950m to end litigation
04/03	Moderna rises as up to $2.25 billion settlement for COVID vaccine patent dispute to remove overhang
04/03	Moderna va payer 950 millions de dollars pour mettre fin à des litiges
04/03	USA-Les valeurs à suivre à Wall Street (actualisé)
03/03	Moderna Enters Settlement Agreement with Arbutus Biopharma, Genevant Sciences
03/03	Moderna agrees to pay up to $2.25 billion to settle COVID vaccine patent dispute
03/03	Roivant announces Genevant Sciences' and Arbutus Biopharma's $2.25 billion global settlement with Moderna
03/03	Genevant Sciences and Arbutus Biopharma announce $2.25 billion global settlement with Moderna
03/03	Genevant Sciences and Arbutus Biopharma Announce $2.25 Billion Global Settlement With Moderna
18/02	Moderna Loses Two Defenses in Patent Infringement Case Against Arbutus Biopharma